OTCMKTS:JBPHF Jacobio Pharmaceuticals Group (JBPHF) Stock Price, News & Analysis $0.76 0.00 (0.00%) As of 11/13/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartNews and Trends About Jacobio Pharmaceuticals Group Stock (OTCMKTS:JBPHF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get JBPHF alerts:Sign Up Key Stats Today's Range$0.76▼$0.7650-Day Range$0.68▼$0.7652-Week Range$0.60▼$0.76VolumeN/AAverage Volume1,180 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Jacobio Pharmaceuticals Group is a China-based biopharmaceutical company focused on discovering and developing innovative medicines, particularly for cancer. Its work includes research, drug development and clinical testing of therapies aimed at specific molecular targets. The company’s oncology pipeline includes glecirasib (JAB-21822), a candidate that targets KRAS G12C, as well as other investigational medicines directed at cancer-related pathways. Jacobio conducts research and clinical development in China and has pursued development activities in the United States.AI Generated. May Contain Errors. Read More Receive JBPHF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Jacobio Pharmaceuticals Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. JBPHF Stock News HeadlinesJacobio Advances KRAS Oncology Pipeline as Glecirasib Gains Traction in ChinaAugust 24, 2026 | tipranks.comJacobio Pharmaceuticals Sets Board Meeting to Approve Interim 2026 ResultsAugust 12, 2026 | tipranks.comManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 in one quarter. Institutions own about 83% of shares, including BlackRock's 32 million shares worth $716 million and Vanguard's 48 million shares worth nearly $1.1 billion. A new multi-year deal with Palantir adds an AI-driven edge to this energy producer's operations.November 16 at 1:00 AM | Monument Traders Alliance (Ad)Jacobio Pharmaceuticals Forecasts First Interim Profit on Licensing-Driven Revenue SurgeAugust 10, 2026 | tipranks.comJacobio Starts Phase IIa Trial of First BET Inhibitor for Rheumatoid Arthritis in ChinaJuly 26, 2026 | tipranks.comJacobio Starts Phase Ib/III Trial of Pan-KRAS Inhibitor for KRAS-Mutant Pancreatic Cancer in ChinaJuly 19, 2026 | tipranks.comJacobio Pharmaceuticals Launches HK$100 Million Share Buyback PlanJune 7, 2026 | tipranks.comJacobio Shareholders Back All Resolutions at 2026 AGM, Renewing Capital MandatesJune 5, 2026 | tipranks.comSee More Headlines JBPHF Stock Analysis - Frequently Asked Questions How have JBPHF shares performed this year? Jacobio Pharmaceuticals Group's stock was trading at $0.9479 at the start of the year. Since then, JBPHF stock has decreased by 20.3% and is now trading at $0.7552. How do I buy shares of Jacobio Pharmaceuticals Group? Shares of JBPHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:JBPHF CIKN/A Webwww.jacobiopharma.com Phone86-10-5631-5466FaxN/AEmployees301Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (OTCMKTS:JBPHF) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersMy $247 scanner for $7Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment t...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredA Nasdaq drone company just landed a deal with a Philippine billionaire's groupA Nasdaq-listed drone company just signed an exclusive agreement with Prime Strategic Holdings, part of billio...The Tomorrow Investor | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jacobio Pharmaceuticals Group Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jacobio Pharmaceuticals Group With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.